APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transforming Growth Factor Beta 1

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Selected research

Market Outlook & Growth Opportunities

Global Transforming Growth Factor Beta 1 Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchTransforming Growth Factor Beta 1 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Transforming Growth Factor Beta 1 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transforming Growth Factor Beta 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transforming Growth Factor Beta 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

This report provides an overview of the global Transforming Growth Factor Beta 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Transforming Growth Factor Beta 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transforming Growth Factor Beta 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transforming Growth Factor Beta 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Transforming Growth Factor Beta 1 Segment by Company

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Transforming Growth Factor Beta 1 Segment by Type

Pirfenidone

Galunisertib

Others

Transforming Growth Factor Beta 1 Segment by Application

IPF

Cancer

Others

Transforming Growth Factor Beta 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transforming Growth Factor Beta 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transforming Growth Factor Beta 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transforming Growth Factor Beta 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Transforming Growth Factor Beta 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transforming Growth Factor Beta 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transforming Growth Factor Beta 1 industry.

Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transforming Growth Factor Beta 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transforming Growth Factor Beta 1 Industry Trends Table 2. Transforming Growth Factor Beta 1 Industry Drivers Table 3. Transforming Growth Factor Beta 1 Industry Opportunities and Challenges Table 4. Transforming Growth Factor Beta 1 Industry Restraints Table 5. Global Transforming Growth Factor Beta 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transforming Growth Factor Beta 1 Revenue Share by Company (2021-2026) Table 7. Global Transforming Growth Factor Beta 1 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Transforming Growth Factor Beta 1 Sales Volume Share by Company (2021-2026) Table 9. Global Transforming Growth Factor Beta 1 Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Transforming Growth Factor Beta 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transforming Growth Factor Beta 1 Key Company Manufacturing Base & Headquarters Table 12. Global Transforming Growth Factor Beta 1 Company, Product Type & Application Table 13. Global Transforming Growth Factor Beta 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pirfenidone Table 18. Significant Companies of Galunisertib Table 19. Significant Companies of Others Table 20. Global Transforming Growth Factor Beta 1 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Transforming Growth Factor Beta 1 Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Transforming Growth Factor Beta 1 Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Transforming Growth Factor Beta 1 Sales Volume Share by Type (2021-2026) Table 24. Global Transforming Growth Factor Beta 1 Sales Volume Share by Type (2027-2032) Table 25. Global Transforming Growth Factor Beta 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transforming Growth Factor Beta 1 Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Transforming Growth Factor Beta 1 Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Transforming Growth Factor Beta 1 Sales Value Share by Type (2021-2026) Table 29. Global Transforming Growth Factor Beta 1 Sales Value Share by Type (2027-2032) Table 30. Significant Companies of IPF Table 31. Significant Companies of Cancer Table 32. Significant Companies of Others Table 33. Global Transforming Growth Factor Beta 1 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Transforming Growth Factor Beta 1 Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Transforming Growth Factor Beta 1 Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Transforming Growth Factor Beta 1 Sales Volume Share by Application (2021-2026) Table 37. Global Transforming Growth Factor Beta 1 Sales Volume Share by Application (2027-2032) Table 38. Global Transforming Growth Factor Beta 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Transforming Growth Factor Beta 1 Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Transforming Growth Factor Beta 1 Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Transforming Growth Factor Beta 1 Sales Value Share by Application (2021-2026) Table 42. Global Transforming Growth Factor Beta 1 Sales Value Share by Application (2027-2032) Table 43. Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026) & (K Units) Table 45. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021-2026) Table 46. Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032) & (K Units) Table 47. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2027-2032) Table 48. Global Transforming Growth Factor Beta 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Transforming Growth Factor Beta 1 Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Transforming Growth Factor Beta 1 Sales Value Share by Region (2021-2026) Table 51. Global Transforming Growth Factor Beta 1 Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Transforming Growth Factor Beta 1 Sales Value Share by Region (2027-2032) Table 53. Global Transforming Growth Factor Beta 1 Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Transforming Growth Factor Beta 1 Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Transforming Growth Factor Beta 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 58. Global Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 59. Global Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 60. Global Transforming Growth Factor Beta 1 Sales Market Share by Country (2027-2032) Table 61. Global Transforming Growth Factor Beta 1 Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Transforming Growth Factor Beta 1 Sales Value Market Share by Country (2021-2026) Table 63. Global Transforming Growth Factor Beta 1 Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Transforming Growth Factor Beta 1 Sales Value Market Share by Country (2027-2032) Table 65. Roche Company Information Table 66. Roche Business Overview Table 67. Roche Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Roche Transforming Growth Factor Beta 1 Product Portfolio Table 69. Roche Recent Development Table 70. Shionogi Ltd Company Information Table 71. Shionogi Ltd Business Overview Table 72. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio Table 74. Shionogi Ltd Recent Development Table 75. Acceleron Pharma Inc Company Information Table 76. Acceleron Pharma Inc Business Overview Table 77. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio Table 79. Acceleron Pharma Inc Recent Development Table 80. Genzyme Corp Company Information Table 81. Genzyme Corp Business Overview Table 82. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio Table 84. Genzyme Corp Recent Development Table 85. Isarna Therapeutics GmbH Company Information Table 86. Isarna Therapeutics GmbH Business Overview Table 87. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio Table 89. Isarna Therapeutics GmbH Recent Development Table 90. Scholar Rock Company Information Table 91. Scholar Rock Business Overview Table 92. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio Table 94. Scholar Rock Recent Development Table 95. Sirnaomics Inc Company Information Table 96. Sirnaomics Inc Business Overview Table 97. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 99. Sirnaomics Inc Recent Development Table 100. Eli Lilly and Co Company Information Table 101. Eli Lilly and Co Business Overview Table 102. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio Table 104. Eli Lilly and Co Recent Development Table 105. Formation Biologics Inc Company Information Table 106. Formation Biologics Inc Business Overview Table 107. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 109. Formation Biologics Inc Recent Development Table 110. Novartis AG Company Information Table 111. Novartis AG Business Overview Table 112. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Novartis AG Transforming Growth Factor Beta 1 Product Portfolio Table 114. Novartis AG Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Transforming Growth Factor Beta 1 Distributors List Table 118. Transforming Growth Factor Beta 1 Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Transforming Growth Factor Beta 1 Product Image Figure 2. Global Transforming Growth Factor Beta 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transforming Growth Factor Beta 1 Sales (2021-2032) & (K Units) Figure 5. Global Transforming Growth Factor Beta 1 Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Transforming Growth Factor Beta 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pirfenidone Image Figure 10. Galunisertib Image Figure 11. Others Image Figure 12. Global Transforming Growth Factor Beta 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Transforming Growth Factor Beta 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Transforming Growth Factor Beta 1 Sales Volume Share by Type (2021-2032) Figure 15. Global Transforming Growth Factor Beta 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Transforming Growth Factor Beta 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Transforming Growth Factor Beta 1 Sales Value Share by Type (2021-2032) Figure 18. IPF Image Figure 19. Cancer Image Figure 20. Others Image Figure 21. Global Transforming Growth Factor Beta 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Transforming Growth Factor Beta 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Transforming Growth Factor Beta 1 Sales Volume Share by Application (2021-2032) Figure 24. Global Transforming Growth Factor Beta 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Transforming Growth Factor Beta 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Transforming Growth Factor Beta 1 Sales Value Share by Application (2021-2032) Figure 27. Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Transforming Growth Factor Beta 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Transforming Growth Factor Beta 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Transforming Growth Factor Beta 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 32. North America Transforming Growth Factor Beta 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Transforming Growth Factor Beta 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Transforming Growth Factor Beta 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 38. South America Transforming Growth Factor Beta 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Transforming Growth Factor Beta 1 Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Transforming Growth Factor Beta 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Transforming Growth Factor Beta 1 Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Transforming Growth Factor Beta 1 Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Pirfenidone
  • Galunisertib
  • Others
Applications
  • IPF
  • Cancer
  • Others
Companies covered
  • Roche
  • Shionogi Ltd
  • Acceleron Pharma Inc
  • Genzyme Corp
  • Isarna Therapeutics GmbH
  • Scholar Rock
  • Sirnaomics Inc
  • Eli Lilly and Co
  • Formation Biologics Inc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  4. 1.2.2 Global Transforming Growth Factor Beta 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Transforming Growth Factor Beta 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transforming Growth Factor Beta 1 Market Dynamics
  1. 2.1 Transforming Growth Factor Beta 1 Industry Trends
  2. 2.2 Transforming Growth Factor Beta 1 Industry Drivers
  3. 2.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
  4. 2.4 Transforming Growth Factor Beta 1 Industry Restraints
3 Transforming Growth Factor Beta 1 Market by Company
  1. 3.1 Global Transforming Growth Factor Beta 1 Company Revenue Ranking in 2025
  2. 3.2 Global Transforming Growth Factor Beta 1 Revenue by Company (2021-2026)
  3. 3.3 Global Transforming Growth Factor Beta 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Transforming Growth Factor Beta 1 Average Price by Company (2021-2026)
  5. 3.5 Global Transforming Growth Factor Beta 1 Company Ranking (2024-2026)
  6. 3.6 Global Transforming Growth Factor Beta 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Transforming Growth Factor Beta 1 Company Product Type and Application
  8. 3.8 Global Transforming Growth Factor Beta 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transforming Growth Factor Beta 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transforming Growth Factor Beta 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transforming Growth Factor Beta 1 Market by Type
  1. 4.1 Transforming Growth Factor Beta 1 Type Introduction
  2. 4.1.1 Pirfenidone
  3. 4.1.2 Galunisertib
  4. 4.1.3 Others
  5. 4.2 Global Transforming Growth Factor Beta 1 Sales Volume by Type
  6. 4.2.1 Global Transforming Growth Factor Beta 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Transforming Growth Factor Beta 1 Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Transforming Growth Factor Beta 1 Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Transforming Growth Factor Beta 1 Sales Value by Type
  10. 4.3.1 Global Transforming Growth Factor Beta 1 Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Transforming Growth Factor Beta 1 Sales Value by Type (2021-2032)
  12. 4.3.3 Global Transforming Growth Factor Beta 1 Sales Value Share by Type (2021-2032)
5 Transforming Growth Factor Beta 1 Market by Application
  1. 5.1 Transforming Growth Factor Beta 1 Application Introduction
  2. 5.1.1 IPF
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Transforming Growth Factor Beta 1 Sales Volume by Application
  6. 5.2.1 Global Transforming Growth Factor Beta 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transforming Growth Factor Beta 1 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Transforming Growth Factor Beta 1 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Transforming Growth Factor Beta 1 Sales Value by Application
  10. 5.3.1 Global Transforming Growth Factor Beta 1 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transforming Growth Factor Beta 1 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Transforming Growth Factor Beta 1 Sales Value Share by Application (2021-2032)
6 Transforming Growth Factor Beta 1 Regional Sales and Value Analysis
  1. 6.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transforming Growth Factor Beta 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032)
  5. 6.3 Global Transforming Growth Factor Beta 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transforming Growth Factor Beta 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transforming Growth Factor Beta 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transforming Growth Factor Beta 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Transforming Growth Factor Beta 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  12. 6.6.2 North America Transforming Growth Factor Beta 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Transforming Growth Factor Beta 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transforming Growth Factor Beta 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  21. 6.9.2 South America Transforming Growth Factor Beta 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales Value Share by Country, 2025 VS 2032
7 Transforming Growth Factor Beta 1 Country-level Sales and Value Analysis
  1. 7.1 Global Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transforming Growth Factor Beta 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transforming Growth Factor Beta 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Transforming Growth Factor Beta 1 Sales by Country (2027-2032)
  6. 7.4 Global Transforming Growth Factor Beta 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transforming Growth Factor Beta 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transforming Growth Factor Beta 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transforming Growth Factor Beta 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transforming Growth Factor Beta 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transforming Growth Factor Beta 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Shionogi Ltd
  8. 8.2.1 Shionogi Ltd Company Information
  9. 8.2.2 Shionogi Ltd Business Overview
  10. 8.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
  12. 8.2.5 Shionogi Ltd Recent Developments
  13. 8.3 Acceleron Pharma Inc
  14. 8.3.1 Acceleron Pharma Inc Company Information
  15. 8.3.2 Acceleron Pharma Inc Business Overview
  16. 8.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
  18. 8.3.5 Acceleron Pharma Inc Recent Developments
  19. 8.4 Genzyme Corp
  20. 8.4.1 Genzyme Corp Company Information
  21. 8.4.2 Genzyme Corp Business Overview
  22. 8.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
  24. 8.4.5 Genzyme Corp Recent Developments
  25. 8.5 Isarna Therapeutics GmbH
  26. 8.5.1 Isarna Therapeutics GmbH Company Information
  27. 8.5.2 Isarna Therapeutics GmbH Business Overview
  28. 8.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
  30. 8.5.5 Isarna Therapeutics GmbH Recent Developments
  31. 8.6 Scholar Rock
  32. 8.6.1 Scholar Rock Company Information
  33. 8.6.2 Scholar Rock Business Overview
  34. 8.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
  36. 8.6.5 Scholar Rock Recent Developments
  37. 8.7 Sirnaomics Inc
  38. 8.7.1 Sirnaomics Inc Company Information
  39. 8.7.2 Sirnaomics Inc Business Overview
  40. 8.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
  42. 8.7.5 Sirnaomics Inc Recent Developments
  43. 8.8 Eli Lilly and Co
  44. 8.8.1 Eli Lilly and Co Company Information
  45. 8.8.2 Eli Lilly and Co Business Overview
  46. 8.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
  48. 8.8.5 Eli Lilly and Co Recent Developments
  49. 8.9 Formation Biologics Inc
  50. 8.9.1 Formation Biologics Inc Company Information
  51. 8.9.2 Formation Biologics Inc Business Overview
  52. 8.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
  54. 8.9.5 Formation Biologics Inc Recent Developments
  55. 8.10 Novartis AG
  56. 8.10.1 Novartis AG Company Information
  57. 8.10.2 Novartis AG Business Overview
  58. 8.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
  60. 8.10.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transforming Growth Factor Beta 1 Value Chain Analysis
  2. 9.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transforming Growth Factor Beta 1 Sales Mode & Process
  6. 9.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transforming Growth Factor Beta 1 Distributors
  9. 9.2.3 Transforming Growth Factor Beta 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst